Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12516110 | CTHRC1-specific antibody and use thereof | 🖼🧊📄§ | 2026-01-06 | 2041-12-13 | 0 | 31 |
| 12516353 | Recombinant herpesvirus of turkeys (HVT) and preparation method and use thereof | 🖼🧊📄§ | 2026-01-06 | 2042-04-12 | 0 | 31 |
| 12514910 | Medicament for therapeutic treatment and/or improvement of sepsis accompanied by coagulopathy | 🖼🧊📄§ | 2026-01-06 | 2039-08-01 | 0 | 31 |
| 12516127 | Anti-SIRP-alpha antibodies | 🖼🧊📄§ | 2026-01-06 | 2042-11-14 | 0 | 31 |
| 12516112 | Single-chain chimeric polypeptides and uses thereof | 🖼🧊📄§ | 2026-01-06 | 2044-05-20 | 0 | 31 |
| 12514881 | Use of nocardia rubra cell wall skeleton in regenerative medicine | 🖼🧊📄§ | 2026-01-06 | 2041-01-20 | 0 | 31 |
| 12516318 | Targeting glioblastoma stem cells through the TLX-TET3 axis | 🖼🧊📄§ | 2026-01-06 | 2042-05-11 | 0 | 31 |
| 12514900 | Method to identify responders to osteoarthritis therapeutics | 🖼🧊📄§ | 2026-01-06 | 2041-09-27 | 0 | 31 |
| 12514921 | Compositions and methods for treating HIV infection and reversing HIV latency | 🖼🧊📄§ | 2026-01-06 | 2040-06-26 | 0 | 31 |
| 12514882 | Faecalibacterium prausnitzii strain EB-FPDK11 and use thereof | 🖼🧊📄§ | 2026-01-06 | 2040-06-26 | 0 | 31 |
| 12514840 | Treatment of idiopathic hypohidrosis | 🖼🧊📄§ | 2026-01-06 | 2040-08-17 | 0 | 31 |
| 12516115 | Composition for prophylaxis or treatment of IL-8 related diseases | 🖼🧊📄§ | 2026-01-06 | 2043-08-16 | 0 | 31 |
| 12516081 | Anti-viral compounds and methods of use | 🖼🧊📄§ | 2026-01-06 | 2041-06-15 | 0 | 31 |
| 12516085 | Methods and compositions for treating Myc-driven cancers | 🖼🧊📄§ | 2026-01-06 | 2040-09-18 | 0 | 31 |
| 12514893 | Food supplement for use as coadjuvant in the prevention and treatment of cognitive decline associated with Alzheimer disease | 🖼🧊📄§ | 2026-01-06 | 2042-04-22 | 0 | 31 |
| 12514927 | Immunotherapy with combination therapy comprising an immunotoxin | 🖼🧊📄§ | 2026-01-06 | 2040-10-29 | 0 | 31 |
| 12516080 | Remdesivir and remdesivir analogs, solutions, and nanoparticle, liposomal, and microparticle compositions for treating viral infections | 🖼🧊📄§ | 2026-01-06 | 2041-04-01 | 0 | 31 |
| 12516301 | Optimized SUMF1 genes and expression cassettes and their use | 🖼🧊📄§ | 2026-01-06 | 2040-04-28 | 0 | 31 |
| 12516108 | Monoclonal antibodies against the hemagglutinin (HA) and neuraminidase (NA) of in-fluenza H3N2 viruses | 🖼🧊📄§ | 2026-01-06 | 2041-03-25 | 0 | 31 |
| 12516022 | Derivatives of aryl hydrocarbon receptor agonists | 🖼🧊📄§ | 2026-01-06 | 2043-10-20 | 0 | 31 |
| 12514819 | Colchicine drug-to-drug interactions | 🖼🧊📄§ | 2026-01-06 | 2043-04-28 | 0 | 31 |
| 12516306 | Blood glucose stabilizing methods and compositions | 🖼🧊📄§ | 2026-01-06 | 2043-12-12 | 0 | 31 |
| 12516296 | Vaccines for treating SARS infections in cancer patients | 🖼🧊📄§ | 2026-01-06 | 2042-04-26 | 0 | 31 |
| 12514851 | Use of 2,3,5-substituted thiophene compound for preventing, ameliorating, or treating ovarian cancer | 🖼🧊📄§ | 2026-01-06 | 2041-03-04 | 0 | 31 |
| 12514874 | Antiseptic applications of metal nanoparticle agglomerates | 🖼🧊📄§ | 2026-01-06 | 2041-08-03 | 0 | 31 |
| 12514938 | Fibroblast activation protein targeting peptides | 🖼🧊📄§ | 2026-01-06 | 2044-10-29 | 0 | 31 |
| 12514912 | Compositions comprising three OspA fusion proteins for medical use | 🖼🧊📄§ | 2026-01-06 | 2041-04-09 | 0 | 31 |
| 12516118 | Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodies and anti-CD79b antibody drug conjugates | 🖼🧊📄§ | 2026-01-06 | 2041-11-02 | 0 | 31 |
| 12514820 | Pharmaceutical composition of intra-articular corticosteroid for pain control | 🖼🧊📄§ | 2026-01-06 | 2041-08-05 | 0 | 31 |
| 12514871 | Pegylated menaquinol compositions and methods of treatment | 🖼🧊📄§ | 2026-01-06 | 2043-05-26 | 0 | 31 |
| 12514917 | Senecavirus A virus strains and immunogenic compositions therefrom | 🖼🧊📄§ | 2026-01-06 | 2040-07-15 | 0 | 31 |
| 12516092 | Peptide ligands of the GDNF family receptor A-like (GFRAL) receptor | 🖼🧊📄§ | 2026-01-06 | 2040-02-05 | 0 | 31 |
| 12514828 | Methods of permeabilizing the blood brain barrier | 🖼🧊📄§ | 2026-01-06 | 2044-12-17 | 0 | 31 |
| 12516128 | EpCAM binding proteins and methods of use | 🖼🧊📄§ | 2026-01-06 | 2040-05-14 | 0 | 31 |
| 12516331 | Monocyte-specific aptamers and uses thereof for enhancing drug delivery to cancer | 🖼🧊📄§ | 2026-01-06 | 2041-05-26 | 0 | 31 |
| 12514814 | Composition containing extract of Lilium hansonii leichtlin ex baker | 🖼🧊📄§ | 2026-01-06 | 2040-08-28 | 0 | 31 |
| 12516056 | Compounds for inhibition of janus kinase 1 | 🖼🧊📄§ | 2026-01-06 | 2040-05-26 | 0 | 31 |
| 12514858 | CD38 inhibitors | 🖼🧊📄§ | 2026-01-06 | 2041-04-06 | 0 | 31 |
| 12514862 | Testosterone containing pharmaceutical composition | 🖼🧊📄§ | 2026-01-06 | 2041-01-18 | 0 | 31 |
| 12514866 | Method for treating cancer | 🖼🧊📄§ | 2026-01-06 | 2042-01-19 | 0 | 31 |
| 12514908 | Semaglutide depot systems and use thereof | 🖼🧊📄§ | 2026-01-06 | 2042-07-04 | 0 | 31 |
| 12514890 | Plant exosomes used for treatment of diseases originating from protein aggregates formed in cells | 🖼🧊📄§ | 2026-01-06 | 2040-07-30 | 0 | 31 |
| 12514834 | Pharmaceutical composition for treating and/or preventing renal cystic ciliopathy | 🖼🧊📄§ | 2026-01-06 | 2045-01-30 | 0 | 31 |
| 12516307 | Modified porcine pancreatic elastase proteins | 🖼🧊📄§ | 2026-01-06 | 2041-08-18 | 0 | 31 |
| 12514907 | Treatment of exercise-induced hypoglycemia in type 1 and insulin using type 2 diabetes | 🖼🧊📄§ | 2026-01-06 | 2043-07-24 | 0 | 31 |
| 12516309 | Method of treating infections by bacteriolytic enzymes and manufacture thereof | 🖼🧊📄§ | 2026-01-06 | 2040-10-31 | 0 | 31 |
| 12516058 | Small-molecule compounds for controlling endosomal toll-like receptors and therapeutic agent for autoimmune diseases using same | 🖼🧊📄§ | 2026-01-06 | 2041-11-25 | 0 | 31 |
| 12514901 | AD36E4ORF1: a therapeutic treatment for Alzheimer's disease | 🖼🧊📄§ | 2026-01-06 | 2040-08-07 | 0 | 31 |
| 12514853 | Therapeutic dendrimer | 🖼🧊📄§ | 2026-01-06 | 2039-11-20 | 0 | 31 |
| 12516123 | Anti-PD-L1 antibody and pharmaceutical use thereof | 🖼🧊📄§ | 2026-01-06 | 2039-10-21 | 0 | 31 |